亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

926. Risk factors for post-letermovir cytomegalovirus (CMV) reactivation in allogeneic hematopoietic stem cell transplant (HSCT) recipients

医学 内科学 单变量分析 入射(几何) 逻辑回归 回顾性队列研究 队列 造血干细胞移植 移植 多元分析 物理 光学
作者
Maria A. Mendoza,Matthew Thoendel,Raymund R. Razonable,Hassan B. Alkhateeb
出处
期刊:Open Forum Infectious Diseases [Oxford University Press]
卷期号:10 (Supplement_2)
标识
DOI:10.1093/ofid/ofad500.971
摘要

Abstract Background Letermovir (LTMV) is approved for CMV prophylaxis during the first 100 days after HSCT. Thereafter, CMV reactivation (CMVr) may still occur. This study aims to evaluate the incidence and risk factors for any CMVr and clinically significant CMV infection (csCMVi) in patients who received LTMV prophylaxis. Methods Retrospective multicenter cohort study of HSCT patients who received 100 days of LTMV prophylaxis from 08/2018 to 09/2022. Categorical and continuous variables were compared with Fisher’s exact and Kruskal-Wallis test respectively. Logistic regression was used to identify risk factors. Results Of 115 HSCT patients, 28 had CMVr after LTMV prophylaxis (Table 1), including 21 with csCMVi (Table 2). Of note, 29 (25.2%) patients had breakthrough CMV during LTMV prophylaxis. Among 28 cases of post-LTMV CMVr, DNAemia occurred with a median of 38.5 (31.3 – 47) days after stopping LTMV. The median absolute lymphocyte count (ALC) at diagnosis was 1.29 (0.41 – 2.04) x109cells/L. Median peak CMV DNAemia at was 482 (100.5 – 2600) IU/mL, with a duration of 29 (20- 35) days; none had end organ disease. All were receiving immunosuppression for graft-versus-host disease treatment (n=18) or prophylaxis (n=10). Risk factors for CMVr and csCMVi are listed in Table 3. For CMVr, univariate analysis showed that CMV D-/R+ status is associated with increased risk, while having CMV D+ donors or acute myeloid leukemia (AML) had lower risk. Multivariable analysis showed D-/R+ status and breakthrough viremia while on LTMV were associated with increased risk. csCMVi in 21 patients were treated with valganciclovir (n=15) or IV ganciclovir (n=6) for a median duration of 37 (25.5 – 50) days. Univariate analysis showed that acute lymphoblastic leukemia (ALL) and reduced intensity conditioning were associated with increased risk, while AML had lower risk of csCMVi. On multivariable analysis, ALL, and D-/R+ had higher risk while AML had lower risk. Demographics and clinical characteristics of allogeneic hematopoietic stem cell recipients with or without late clinically significant CMV infection Conclusion One in four allogeneic HSCT patients who received LTMV developed post-prophylaxis CMVr within 100 to 200 days post-transplant. CMV D-/R+ status had a higher risk for CMVr and csCMVi after LTMV discontinuation. Patients with AML had a lower risk for CMVr and csCMVi. Disclosures Raymund R. Razonable, MD, Allovir: Endpoint Adjudication Committee|American Society of Transplantation: Board Member|Gilead: Grant/Research Support|Novartis: DSMB|Regeneron: Grant/Research Support|Roche: Grant/Research Support
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
乐正亦寒完成签到 ,获得积分10
5秒前
斯文败类应助haha采纳,获得10
8秒前
Swear完成签到 ,获得积分10
13秒前
15秒前
18秒前
19秒前
JingjingYao发布了新的文献求助10
20秒前
行舟完成签到 ,获得积分10
21秒前
太清发布了新的文献求助10
22秒前
江洋大盗发布了新的文献求助10
24秒前
26秒前
WWW完成签到 ,获得积分10
30秒前
鲁丁丁发布了新的文献求助10
30秒前
秋蚓完成签到 ,获得积分10
34秒前
一切随风发布了新的文献求助50
39秒前
超威蓝猫完成签到,获得积分10
43秒前
ztayx完成签到 ,获得积分10
43秒前
图治完成签到,获得积分10
49秒前
rangersl1发布了新的文献求助10
53秒前
55秒前
图治发布了新的文献求助10
56秒前
三横一竖发布了新的文献求助10
1分钟前
bing完成签到 ,获得积分10
1分钟前
oywt完成签到,获得积分20
1分钟前
量子星尘发布了新的文献求助10
1分钟前
1分钟前
1分钟前
冷酷丹翠完成签到 ,获得积分10
1分钟前
555557发布了新的文献求助10
1分钟前
1分钟前
花花完成签到 ,获得积分10
1分钟前
NexusExplorer应助科研通管家采纳,获得10
1分钟前
大个应助科研通管家采纳,获得10
1分钟前
yyyalles应助科研通管家采纳,获得10
1分钟前
Jasper应助心若向阳采纳,获得10
1分钟前
冷静初彤完成签到,获得积分10
1分钟前
科研通AI5应助lf采纳,获得30
1分钟前
1分钟前
1分钟前
1分钟前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976619
求助须知:如何正确求助?哪些是违规求助? 3520720
关于积分的说明 11204567
捐赠科研通 3257359
什么是DOI,文献DOI怎么找? 1798716
邀请新用户注册赠送积分活动 877897
科研通“疑难数据库(出版商)”最低求助积分说明 806613